Part 1. Introduction

• 1.1 Market Definition
• 1.2 Key Benefit
• 1.3 Market Segment

Part 2. Methodology

• 2.1 Primary
• 2.2 Secondary

Part 3. Executive Summary

Part 4. Market Overview

• 4.1 Introduction
• 4.2 Market Size and Forecast
• 4.3 Market Dynamics
  • 4.3.1 Drivers
  • 4.3.2 Restraints
• 4.4 Impact of COVID-19 Pandemic

Part 5. Global Market for Anti-Rheumatics by Drug Class

• 5.1 Corticosteroids
  • 5.1.1 Market Size and Forecast
• 5.2 Disease Modifying Anti-Rheumatic Drugs
  • 5.2.1 Market Size and Forecast
• 5.3 Nonsteroidal Anti-Inflammatory Drugs
  • 5.3.1 Market Size and Forecast
• 5.4 Uric Acid Drugs
  • 5.4.1 Market Size and Forecast
• 5.5 Others
  • 5.5.1 Market Size and Forecast

Part 6. Global Market for Anti-Rheumatics by Type

• 6.1 Over-The-Counter Drugs
  • 6.1.1 Market Size and Forecast
• 6.2 Prescription-Based Drugs
  • 6.2.1 Market Size and Forecast

Part 7. Global Market for Anti-Rheumatics by Region

• 7.1 Asia-Pacific
  • 7.1.1 Market Size and Forecast
• 7.2 Europe
  • 7.2.1 Market Size and Forecast
• 7.3 North America
  • 7.3.1 Market Size and Forecast
• 7.4 Middle East And Africa (Mea)
  • 7.4.1 Market Size and Forecast
• 7.5 South America
  • 7.5.1 Market Size and Forecast

Part 8. Key Competitor Profiles

• 8.1 AbbVie Inc.
• 8.2 Amgen Inc.
• 8.3 Bristol Myers Squibb (BMS)
• 8.4 Eli Lilly And Company
• 8.5 Johnson & Johnson
• 8.6 Merck & Co., Inc.
• 8.7 Novartis AG
• 8.8 Pfizer Inc.
• 8.9 Roche Holding AG
• 8.10 UCB SA

*LIST IS NOT EXHAUSTIVE

Part 9. Patent Analysis

• 9.1 Patent Statistics
• 9.2 Regional Analysis
• 9.3 Trends Analysis

DISCLAIMER

ABOUT GEN CONSULTING COMPANY

The global anti-rheumatics market is projected to grow at a compound annual growth rate (CAGR) of 3.7% during the forecast period 2021-2027, according to the new report published by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global anti-rheumatics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, company share of market leaders, growth rate and market segments.

The anti-rheumatics market is segmented on the basis of drug class, type, and region. The anti-rheumatics market is segmented as below:

By Drug Class:
- corticosteroids
- disease modifying anti-rheumatic drugs
- nonsteroidal anti-inflammatory drugs
- uric acid drugs
- others

By Type:
- over-the-counter drugs
- prescription-based drugs

By Region:
- Asia-Pacific
- Europe
- North America
- Middle East and Africa (MEA)
- South America

The anti-rheumatics industry is characterized by a high level of market share concentration. The market research report covers the analysis of key stake holders of the anti-rheumatics market. Some of the leading players profiled in the report include AbbVie Inc., Amgen Inc., Bristol Myers Squibb (BMS), Eli Lilly And Company, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer Inc., Roche Holding AG, UCB SA, among others.
*list is not exhaustive, request free sample to get a complete list of companies

Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global anti-rheumatics market.
- To classify and forecast the global anti-rheumatics market based on drug class, type, and region.
- To identify drivers and challenges for the global anti-rheumatics market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global anti-rheumatics market.
- To conduct pricing analysis for the global anti-rheumatics market.
- To identify and analyze the profile of leading players operating in the global anti-rheumatics market.

Why Choose This Report
- Gain a reliable outlook of the global anti-rheumatics market forecasts from 2021 to 2027 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.